Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ABBVIE

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 37
  • 0 comments

FDA approve CYCLOSPORINE

Comment Full text

ABBVIE

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 42
  • 0 comments

FDA approve CYCLOSPORINE

Comment Full text

NANJING KING-FRIEND

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 78
  • 0 comments

FDA approve LIRAGLUTIDE

Comment Full text

LUPIN LTD

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 38
  • 0 comments

FDA approve DECITABINE

Comment Full text

GLAND

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 32
  • 0 comments

FDA approve ACETAMINOPHEN

Comment Full text

ANTHEA PHARMA

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 41
  • 0 comments

FDA approve LIDOCAINE HYDROCHLORIDE

Comment Full text

UNIQUE

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 42
  • 0 comments

FDA approve LITHIUM CARBONATE

Comment Full text

GLENMARK PHARMS INC

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 45
  • 0 comments

FDA approve CETIRIZINE HYDROCHLORIDE

Comment Full text

HETERO LABS LTD V

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 42
  • 0 comments

FDA approve DONEPEZIL HYDROCHLORIDE

Comment Full text

TORRENT PHARMS LTD

  • FDA Approval
  • April 09, 2025, 15:07 UTC
  • 42
  • 0 comments

FDA approve MONTELUKAST SODIUM

Comment Full text
  • Previous
  • 142
  • 143
  • 144
  • 145
  • 146
  • Next

Search

News categories

  • Technical Exchange News(10333)
  • Event(1541)
  • SEC News(176744)
  • FDA Approval(9672)
  • Company Report(721)
  • Business News(118363)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin